Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | LGND | LIGAND PHARMACEUTICALS INC | Healthcare | 4,551.0 | $1.4M | 0.34% | +98.0 | +2.2% | $316.09 | -7.7% |
| 42 | — | KINIKSA PHARMACEUTICALS INTL | — | 22,411.0 | $1.4M | 0.33% | +2K | +10.4% | $63.95 | — |
| 43 | CYTK | CYTOKINETICS INC | Healthcare | 16,577.0 | $1.4M | 0.33% | +12K | +285.2% | $85.19 | -10.9% |
| 44 | KURA | KURA ONCOLOGY INC | Healthcare | 128,495.0 | $1.4M | 0.33% | +46K | +55.5% | $10.97 | +2.8% |
| 45 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 55,139.0 | $1.4M | 0.33% | +24K | +77.3% | $25.30 | +14.7% |
| 46 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 63,720.0 | $1.4M | 0.33% | +22K | +53.8% | $21.86 | -9.6% |
| 47 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 35,400.0 | $1.4M | 0.32% | +29K | +429.5% | $39.12 | +8.5% |
| 48 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 53,688.0 | $1.4M | 0.32% | +39K | +254.0% | $25.72 | -5.3% |
| 49 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 38,711.0 | $1.4M | 0.32% | +509.0 | +1.3% | $35.39 | +2.4% |
| 50 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 75,956.0 | $1.4M | 0.32% | +37K | +93.7% | $17.97 | +1.2% |
| 51 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 3,657.0 | $1.4M | 0.32% | +208.0 | +6.0% | $371.67 | -9.7% |
| 52 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 171,264.0 | $1.4M | 0.32% | +133K | +350.3% | $7.92 | +7.6% |
| 53 | NUVB | NUVATION BIO INC | Healthcare | 236,358.0 | $1.3M | 0.31% | +136K | +136.0% | $5.68 | +14.1% |
| 54 | IRWD | IRONWOOD PHARMACEUTICALS INC | Healthcare | 318,598.0 | $1.3M | 0.31% | +242K | +318.3% | $4.21 | +3.6% |
| 55 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 133,664.0 | $1.3M | 0.31% | +22K | +19.9% | $10.00 | -0.6% |
| 56 | — | ZYMEWORKS INC | — | 50,825.0 | $1.3M | 0.31% | +40K | +374.9% | $26.14 | — |
| 57 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 16,732.0 | $1.3M | 0.30% | +3K | +23.3% | $78.27 | +31.6% |
| 58 | LQDA | LIQUIDIA CORPORATION | Healthcare | 16,326.0 | $1.3M | 0.30% | +8K | +99.8% | $79.73 | -2.5% |
| 59 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 2,419.0 | $1.3M | 0.30% | +943.0 | +63.9% | $536.95 | -2.2% |
| 60 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 10,593.0 | $1.3M | 0.30% | +8K | +270.4% | $122.58 | +29.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%